Inferensys

Glossary

Patient Recruitment Acceleration

Patient recruitment acceleration is the application of automated screening technologies to rapidly identify and engage eligible participants, directly reducing the timeline and cost of clinical trial enrollment.
Developer reviewing LLM cost optimization spreadsheet on laptop, calculator and coffee on desk, casual finance-technical moment.
CLINICAL TRIAL ENROLLMENT

What is Patient Recruitment Acceleration?

Patient recruitment acceleration is the application of automated screening technologies to rapidly identify and engage eligible participants, directly reducing the timeline and cost of clinical trial enrollment.

Patient recruitment acceleration is the systematic application of AI-driven clinical trial matching algorithms and patient pre-screening technologies to dramatically reduce the time required to identify, validate, and enroll qualified subjects. By automating the parsing of unstructured medical records against complex eligibility criteria, it replaces manual chart review with high-throughput computational screening that can evaluate thousands of patient records in minutes.

This approach leverages computable phenotypes and patient vector embeddings to perform semantic comparisons between a patient's longitudinal clinical profile and a trial's inclusion-exclusion logic. The result is a prioritized, ranked list of pre-qualified candidates that enables clinical operations teams to bypass the traditional bottleneck of manual recruitment, directly addressing the industry-wide problem of costly enrollment delays and screen failure rates.

ACCELERATED ENROLLMENT

Key Features of Patient Recruitment Acceleration

Automated screening technologies that transform the clinical trial enrollment timeline by rapidly identifying and engaging eligible participants from real-world data sources.

01

Automated Pre-Screening Pipelines

Deploy privacy-preserving algorithms that perform an initial assessment of patient suitability using minimal demographic and diagnostic data before full record review.

  • Reduces manual chart review time by up to 90%
  • Operates on de-identified data to maintain HIPAA compliance
  • Integrates directly with EHR systems via Trial Pre-Screening APIs
  • Flags potentially eligible patients within seconds, not weeks
< 5 sec
Initial Screen Time
90%
Manual Review Reduction
02

Semantic Patient-Trial Matching

Utilize patient vector embeddings to transform clinical profiles into dense numerical representations, enabling semantic similarity comparisons against trial requirements.

  • Goes beyond keyword matching to understand clinical context
  • Identifies patients with atypical presentations that still meet criteria
  • Enables ranked candidate lists through eligibility scoring
  • Supports hybrid matching architectures combining deterministic rules with probabilistic semantic search
03

Real-World Data Screening

Apply clinical trial matching algorithms to non-interventional data sources including electronic health records, claims databases, and patient registries.

  • Taps into vast pools of existing clinical data
  • Identifies patients who may not be actively seeking trials
  • Supports site feasibility assessments by estimating eligible populations
  • Enables biomarker-driven screening for precision medicine trials
04

Criteria-to-Query Translation

Convert parsed, structured eligibility criteria into executable database queries such as SQL or FHIR API calls to screen patient repositories at scale.

  • Automates the translation of free-text protocol criteria into machine-readable logic
  • Handles temporal reasoning for time-dependent constraints like washout periods
  • Supports concomitant medication checking against prohibited drug lists
  • Adapts to protocol amendments through automated logic updates
05

Screen Failure Analysis & Optimization

Systematically analyze why pre-screened patients failed to meet trial eligibility, creating a feedback loop that refines recruitment strategies.

  • Identifies overly restrictive inclusion/exclusion criteria
  • Reveals patterns in criteria weighting that may need adjustment
  • Informs protocol design for future trials
  • Reduces costly recruitment delays through continuous improvement
06

Genomic & Biomarker Eligibility

Automate the comparison of structured genomic variant data against molecular biomarker requirements such as EGFR mutation status or PD-L1 expression levels.

  • Accelerates precision medicine trial enrollment
  • Supports master protocol screening across basket and umbrella trials
  • Integrates with clinical event sequencing to validate treatment history
  • Enables simultaneous evaluation against multiple sub-study arms
PATIENT RECRUITMENT ACCELERATION

Frequently Asked Questions

Clear, technical answers to the most common questions about using automated screening technologies to reduce clinical trial enrollment timelines and costs.

Patient recruitment acceleration is the application of automated screening technologies—primarily natural language processing (NLP) and computable phenotyping—to rapidly identify and engage eligible participants for clinical trials. It works by ingesting unstructured patient data from electronic health records (EHRs), parsing complex trial protocols into machine-readable inclusion and exclusion criteria, and executing a matching algorithm that compares a patient's longitudinal clinical profile against those criteria. The output is a ranked list of pre-screened, potentially eligible patients, dramatically reducing the manual chart review burden that typically consumes 30-40% of trial timelines. This process transforms recruitment from a reactive, site-by-site effort into a proactive, data-driven search across entire patient populations.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.